Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.34

-0.3

-0.25

-0.21

Details

Expected EPS

-0.305281

Actual EPS

-0.34

Surprise EPS

-0.03

Surprise Percent

+11.37%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.34 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.